Annie Luetkemeyer, MD, professor of infectious diseases at UCSF, is an expert on the treatment of viral infections. Robert Wachter, MD, MHM, chair of the UCSF Department of Medicine, interviewed her about the evidence behind potential treatments for COVID-19 (including chloroquine/hydroxychloroquine, remdesivir, and others), as well as how to assess new and existing drugs in a pandemic.
© Frontline Medical Communications 2018-2021. Reprinted with permission, all rights reserved.
Drs. Frank and Grant did an outstanding job with their in-person In the Literature at SHM Converge. Whether to use a standard or a personalized dose of corticosteroids in hospitalized patients...
Decline in new vaccinations continues, even among 5- to 11-year-olds.
Most adolescents and young adults recover quickly from the rare complication of myocarditis following mRNA COVID-19 vaccination, a new study shows.
Over 900,000 children aged 5-11 years completed the vaccine regimen in the last week.
